Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2008-02-12 Report Publication Anno…
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2008
Report Publication Announcement Classification · 1% confidence The document is titled "Inbjudan till presentation av senaste rapporten" (Invitation to the presentation of the latest report) and specifically invites participants to a presentation of the full-year financial report (helårsbokslutet 2007) by the CEO on February 13th, followed by a conference call. This structure—an announcement inviting people to an event where results will be discussed, including a conference call number—strongly indicates that this document is an announcement about an upcoming earnings call, rather than the full report (10-K or IR) or the transcript itself (CT). Since it is an invitation to discuss results, it aligns best with the Earnings Release (ER) category, which covers initial announcements of periodical financial results, or potentially a Call Transcript (CT) if it were the transcript itself. Given it is an *invitation* to the presentation/call, it functions as the initial communication regarding the results release event. However, the presence of a specific conference call time and number, and the mention of presenting the 'helårsbokslutet' (full-year report), suggests it is directly related to the earnings event. If the document were the actual transcript, it would be classified as CT. Since it is the *invitation* to the presentation/call, it is most closely related to the Earnings Release (ER) event announcement, or potentially a Report Publication Announcement (RPA) if it were purely announcing the report's availability. Given the focus on the CEO presenting the results and the subsequent conference call, ER is the most appropriate fit for the announcement surrounding the release of annual results.
2008-02-12 Swedish
Legal Proceedings Report 2008
Legal Proceedings Report Classification · 1% confidence The document is a press release dated 2008-01-29 announcing a temporary halt to a clinical study involving Probi's product due to safety concerns raised by an unrelated study. This is a specific operational/scientific update concerning the company's activities, not a standard financial filing like a 10-K, ER, or IR. It does not fit the definitions for AGM-R, MANG, CT, CAP, DVA, DLST, DIRS, AR, SR, FS, CGR, IRAT, LTR, TAR, MRQ, NAV, DIV, DEF 14A, RPA, SHA, or POS. It is not a comprehensive financial report (IR) or an initial earnings release (ER). Since it is a specific, non-standard announcement regarding company operations/research that doesn't fit the other specific categories, the most appropriate fallback category is Regulatory Filings (RNS), as it is a public announcement of a material event that requires disclosure, even if it's not a formal SEC filing type.
2008-01-29 Swedish
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Probi AB covering the period 2007.01.01 to 2007.09.30. It contains detailed financial statements, including income statements per business segment, revenue breakdowns, and management commentary on business performance, research, and development. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2007
2007-10-25 Swedish
Regulatory Filings 2007
Regulatory Filings Classification · 1% confidence The document is a press release dated 2007-09-26 announcing a licensing agreement between Probi and NextFoods for the US market regarding a health food product containing Probi's probiotics. This announcement details a significant business development, specifically a licensing/partnership agreement that guarantees future royalty income. This type of announcement, which details a major business transaction or strategic partnership rather than routine financial results (ER/IR), management changes (MANG), or insider trading (DIRS), fits best under the category of Capital/Financing Update (CAP) if it involves fundraising or capital structure, or more generally, a Regulatory Filing (RNS) if it's a general business update not covered elsewhere. Since this is a major commercial agreement with financial implications (guaranteed royalty), it is a significant corporate event. Given the options, 'TAR' (M&A Activity) is for mergers/takeovers, which this is not. 'CAP' relates to financing/capital structure changes, which this is tangentially related to via royalties, but it's primarily a licensing deal. 'RNS' (Regulatory Filings) is the best general fit for significant, non-standard corporate announcements that don't fit the highly specific categories like ER, 10-K, or MANG. However, looking closely at the definitions, none perfectly capture a 'Licensing Agreement Announcement'. Since it is a material business development announcement, and not a standard financial report, 'RNS' serves as the appropriate catch-all for significant, non-standard corporate news.
2007-09-26 Swedish
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport' (Interim Report) for Probi AB, covering the period 2007.01.01 - 2007.06.30. It contains detailed financial statements, including income statements per business segment, revenue breakdowns, and management commentary on performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2007
2007-07-24 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.